Transcriptional Repressor Activating Transcription Factor 3 Protects Human Umbilical Vein Endothelial Cells from Tumor Necrosis Factor-α-induced Apoptosis through Down-regulation ofp53 Transcription*
暂无分享,去创建一个
A. Noda | M. Sunamori | J. Kawauchi | M. Adachi | Y. Hashimoto | S. Kitajima | Kiyoshi Nobori | Chun Zhang | Junya Kawauchi | Yoshinori Hashimoto
[1] M. Adachi,et al. Expression of transcriptional repressor ATF3/LRF1 in human atherosclerosis: colocalization and possible involvement in cell death of vascular endothelial cells. , 2002, Atherosclerosis.
[2] D. Boyd,et al. ATF3 Represses 72-kDa Type IV Collagenase (MMP-2) Expression by Antagonizing p53-dependent trans-Activation of the Collagenase Promoter* , 2002, The Journal of Biological Chemistry.
[3] Tsonwin Hai,et al. The Roles of ATF3 in Glucose Homeostasis , 2001, The Journal of Biological Chemistry.
[4] K. L. Gardner,et al. Transgenic mice with cardiac-specific expression of activating transcription factor 3, a stress-inducible gene, have conduction abnormalities and contractile dysfunction. , 2001, The American journal of pathology.
[5] N. Holbrook,et al. Protective Role for c-Jun in the Cellular Response to DNA Damage* , 2001, The Journal of Biological Chemistry.
[6] M. Karin,et al. AP-1 Repressor Protein JDP-2: Inhibition of UV-Mediated Apoptosis through p53 Down-Regulation , 2001, Molecular and Cellular Biology.
[7] E. Wagner,et al. The Mammalian UV Response c-Jun Induction Is Required for Exit from p53-Imposed Growth Arrest , 2000, Cell.
[8] R. Davis,et al. Signal Transduction by the JNK Group of MAP Kinases , 2000, Cell.
[9] T. Aso,et al. Homocysteine-responsive ATF3 gene expression in human vascular endothelial cells: activation of c-Jun NH(2)-terminal kinase and promoter response element. , 2000, Blood.
[10] B. Metzler,et al. Increased expression and activation of stress-activated protein kinases/c-Jun NH(2)-terminal protein kinases in atherosclerotic lesions coincide with p53. , 2000, The American journal of pathology.
[11] A. Noda,et al. A unique, short sequence determines p53 gene basal and UV-inducible expression in normal human cells , 2000, Oncogene.
[12] Dirk Bohmann,et al. Diverse functions of JNK signaling and c-Jun in stress response and apoptosis , 1999, Oncogene.
[13] M. Bittner,et al. Fluorescent cDNA microarray hybridization reveals complexity and heterogeneity of cellular genotoxic stress responses , 1999, Oncogene.
[14] H. Esche,et al. Expression of human p53 requires synergistic activation of transcription from the p53 promoter by AP-1, NF-κB and Myc/Max , 1999, Oncogene.
[15] T. W. Fawcett,et al. Complexes containing activating transcription factor (ATF)/cAMP-responsive-element-binding protein (CREB) interact with the CCAAT/enhancer-binding protein (C/EBP)-ATF composite site to regulate Gadd153 expression during the stress response. , 1999, The Biochemical journal.
[16] E. Wagner,et al. Control of cell cycle progression by c-Jun is p53 dependent. , 1999, Genes & development.
[17] S. Berger,et al. p53 Sites Acetylated In Vitro by PCAF and p300 Are Acetylated In Vivo in Response to DNA Damage , 1999, Molecular and Cellular Biology.
[18] R. Yu,et al. Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells , 1999, Oncogene.
[19] Tsonwin Hai,et al. ATF3 and stress responses. , 1999, Gene expression.
[20] A. Lau,et al. Tumor Suppressor p53 as a Component of the Tumor Necrosis Factor-induced, Protein Kinase PKR-mediated Apoptotic Pathway in Human Promonocytic U937 Cells* , 1998, The Journal of Biological Chemistry.
[21] K. Sakaguchi,et al. DNA damage activates p53 through a phosphorylation-acetylation cascade. , 1998, Genes & development.
[22] N. Donato,et al. Tumor Necrosis Factor-induced Apoptosis Stimulates p53 Accumulation and p21WAF1 Proteolysis in ME-180 Cells* , 1998, The Journal of Biological Chemistry.
[23] W. Loging,et al. Transcriptional regulation of the p53 tumor suppressor gene. , 1998, Seminars in cancer biology.
[24] G. Evan,et al. Induction of TNF‐sensitive cellular phenotype by c‐Myc involves p53 and impaired NF‐κB activation , 1997, The EMBO journal.
[25] C. Moyret-Lalle,et al. Resistance of MCF7 human breast carcinoma cells to TNF-induced cell death is associated with loss of p53 function , 1997, Oncogene.
[26] Yoichi Taya,et al. DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2 , 1997, Cell.
[27] Wei Gu,et al. Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain , 1997, Cell.
[28] Tsonwin Hai,et al. Tissue-specific Pattern of Stress Kinase Activation in Ischemic/Reperfused Heart and Kidney* , 1997, The Journal of Biological Chemistry.
[29] S. Elledge,et al. Isolation of an AP-1 repressor by a novel method for detecting protein-protein interactions , 1997, Molecular and cellular biology.
[30] Stephen N. Jones,et al. Regulation of p53 stability by Mdm2 , 1997, Nature.
[31] M. Oren,et al. Mdm2 promotes the rapid degradation of p53 , 1997, Nature.
[32] S. Nagata,et al. Apoptosis by Death Factor , 1997, Cell.
[33] A. Karsan,et al. Endothelial Cell Death Induced by Tumor Necrosis Factor-α Is Inhibited by the Bcl-2 Family Member, A1* , 1996, The Journal of Biological Chemistry.
[34] Michael Karin,et al. Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell Death , 1996, Cell.
[35] M. Ewen,et al. p53 and translational control. , 1996, Biochimica et biophysica acta.
[36] C. Wolfgang,et al. Analysis of ATF3, a transcription factor induced by physiological stresses and modulated by gadd153/Chop10 , 1996, Molecular and cellular biology.
[37] Y. Kanegae,et al. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[38] A. Karsan,et al. Modulation of endothelial cell apoptosis: mechanisms and pathophysiological roles. , 1996, Journal of atherosclerosis and thrombosis.
[39] W. Fiers,et al. Two tumour necrosis factor receptors: structure and function. , 1995, Trends in cell biology.
[40] M. Peterson,et al. Induction of Endothelial Cell Apoptosis by TNFα: Modulation by Inhibitors of Protein Synthesis , 1994 .
[41] Tsonwin Hai,et al. ATF3 and ATF3 delta Zip. Transcriptional repression versus activation by alternatively spliced isoforms. , 1994, The Journal of biological chemistry.
[42] G. Pfeifer,et al. In vivo protein-DNA interactions at the c-jun promoter: preformed complexes mediate the UV response , 1993, Molecular and cellular biology.
[43] K. Tracey,et al. Tumor necrosis factor, other cytokines and disease. , 1993, Annual review of cell biology.
[44] R Taub,et al. Interactions among LRF-1, JunB, c-Jun, and c-Fos define a regulatory program in the G1 phase of liver regeneration , 1992, Molecular and cellular biology.
[45] J. Hsu,et al. Identification of LRF-1, a leucine-zipper protein that is rapidly and highly induced in regenerating liver. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[46] W. Fiers,et al. Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. , 1991, The American journal of pathology.
[47] J. Piette,et al. Protein-binding elements in the promoter region of the mouse p53 gene. , 1990, Oncogene.
[48] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.